These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2856531)

  • 1. Transfusion-associated non-A, non-B hepatitis: an assessment of the causative agent and its clinical impact.
    Alter HJ; Prince AM
    Transfus Med Rev; 1988 Dec; 2(4):288-93. PubMed ID: 2856531
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to hepatitis C and surrogate markers in blood donors.
    Koerner K; Stampe D; Glück D; Kubanek B
    Vox Sang; 1991; 61(2):138-9. PubMed ID: 1662427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological diagnosis of non-A, non-B virus infections from parenteral transfusion and/or sporadic cases].
    Bréchot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):325-33. PubMed ID: 2177593
    [No Abstract]   [Full Text] [Related]  

  • 6. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogate testing for non-A, non-B hepatitis.
    Anderson CC; Contreras M; Barbara JA; Mijovic V
    Lancet; 1987 Apr; 1(8538):912. PubMed ID: 2882303
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
    Janot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present status of transfusion-associated hepatitis C virus infection--efficiency after implementation of nucleic acid amplification testing].
    Takahashi M; Muraoka M; Tadokoro K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):267-71. PubMed ID: 15359805
    [No Abstract]   [Full Text] [Related]  

  • 11. [Post-transfusional non-A non-B hepatitis. Evaluation of SGPT screening in blood donors].
    Muglia M; Angeloni U; Angeloni P
    Boll Ist Sieroter Milan; 1989; 68(1):28-33. PubMed ID: 2518810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the blood supply for non-A, non-B hepatitis. A nonspecific approach for improving transfusion safety has a heterogeneous impact on blood donors.
    Menitove JE
    Am J Clin Pathol; 1990 Apr; 93(4):589-91. PubMed ID: 2108581
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of serum alanine transaminase as a surrogate for hepatitis C virus screening.
    Lu SN; Chang WY; Chen CJ; You SL
    J Clin Gastroenterol; 1992 Jun; 14(4):354-5. PubMed ID: 1318893
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alanine aminotransferase (ALT) assay and incidence of posttransfusion non-A,non-B hepatitis.
    Barcena Marugan R; Zamora C; Moreno A; Erdozain Sosa JC; Perez Hernandez F; Lopez San Roman A
    Transfusion; 1989 Oct; 29(8):751. PubMed ID: 2508279
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion-associated hepatitis C: reducing the risk.
    Gill P
    Transfus Med Rev; 1993 Apr; 7(2):104-11. PubMed ID: 8386960
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 18. [Incidence of anti-HCV and ALT in blood donors].
    Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C
    Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic hepatitis C virus transmission via commercial plasma donation in Spain.
    Davis AR
    Pathology; 1998 Nov; 30(4):427. PubMed ID: 9839323
    [No Abstract]   [Full Text] [Related]  

  • 20. History of posttransfusion hepatitis.
    Tobler LH; Busch MP
    Clin Chem; 1997 Aug; 43(8 Pt 2):1487-93. PubMed ID: 9265899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.